Health economics expert Thomas Ecker and the family office Vantage Value are joining Visionhealth. In addition to the approval of the App Kata as a reimbursable digital health application (DiGA) the Garchingers The money will be used for market entry in Germany. Furthermore, revenue will be generated through collaborations with pharmaceutical and medical technology companies and the use of the app in clinical trials.
The Kata app supports patients in taking their inhalation therapy for respiratory diseases. This allows them to identify and correct errors in the inhalation process and improve treatment outcomes. Studies cited by the startup have shown error rates of more than 32 percent in the use of inhaled medications. The app could significantly improve patient medication administration and save the healthcare system significant costs.
Visionhealth: “Outstanding team and relevant experience”
Erwin J. Schimmer, Managing Director of Vantage Value and new member of the Visionhealth Advisory Board, says:
"We were truly impressed by the effectiveness of Kata's technology, which is based on many years of experience and detailed knowledge of common patient application errors. This is exactly how digital therapy support should work. In the future, digital health apps will become increasingly important in healthcare and will soon become part of everyday practice and clinical routine. With an outstanding team and relevant experience, Visionhealth has recognized this need and implemented it with industry-leading technology."
Sabine Häusermann, CEO and founder of Visionhealth, says:
"We are grateful for the continued support of our existing shareholders and the genuine interest of our new investors. We are confident that Kata will make a difference for many patients and their physicians. We will also use the newly raised funds to expand our partner network and jointly integrate additional inhalers and features into the Kata system. Furthermore, the funds will enable us to demonstrate Kata's beneficial health economic impact as part of the DiGA approval process."
